230 related articles for article (PubMed ID: 33634461)
1. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
[TBL] [Abstract][Full Text] [Related]
2. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
Bonnet U; Specka M; Kanti AK; Scherbaum N
Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
[TBL] [Abstract][Full Text] [Related]
3. Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.
Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Grigoleit T; Hermle L; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Luckhaus C; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck GA; Wodarz N; McAnally H; Scherbaum N
Front Psychiatry; 2020; 11():592199. PubMed ID: 33192740
[No Abstract] [Full Text] [Related]
4. [Comparative Harm/Benefit Analysis of Various Psychotropic Substances from the Perspective of German Drug Users and Addiction Medicine Experts - A Contribution to Psychoeducation of Substance-Addicted Individuals and Restriction/Legalization Debates].
Kanti AK; Specka M; Scherbaum N; Bonnet U
Fortschr Neurol Psychiatr; 2022 Dec; ():. PubMed ID: 36522164
[TBL] [Abstract][Full Text] [Related]
5. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
[TBL] [Abstract][Full Text] [Related]
6. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
[TBL] [Abstract][Full Text] [Related]
7. Perceived harmfulness of substance use: a pilot study.
Sarkar S; Balachander S; Basu D
Indian J Community Med; 2014 Jan; 39(1):26-9. PubMed ID: 24696536
[TBL] [Abstract][Full Text] [Related]
8. The Use of Psychoactive Substances in Germany.
Rauschert C; Möckl J; Seitz NN; Wilms N; Olderbak S; Kraus L
Dtsch Arztebl Int; 2022 Aug; 119(31-32):527-534. PubMed ID: 35791270
[TBL] [Abstract][Full Text] [Related]
9. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
Yu WJ; Cottler L; Li JH
J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland.
Taylor M; Mackay K; Murphy J; McIntosh A; McIntosh C; Anderson S; Welch K
BMJ Open; 2012; 2(4):. PubMed ID: 22833648
[TBL] [Abstract][Full Text] [Related]
11. [Substance use, affective problems and personality traits: test of two association models].
Chakroun N; Doron J; Swendsen J
Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
[TBL] [Abstract][Full Text] [Related]
12. [On the risk of dependence on gabapentinoids].
Bonnet U; Scherbaum N
Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
[TBL] [Abstract][Full Text] [Related]
13. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
14. The Australian drug harms ranking study.
Bonomo Y; Norman A; Biondo S; Bruno R; Daglish M; Dawe S; Egerton-Warburton D; Karro J; Kim C; Lenton S; Lubman DI; Pastor A; Rundle J; Ryan J; Gordon P; Sharry P; Nutt D; Castle D
J Psychopharmacol; 2019 Jul; 33(7):759-768. PubMed ID: 31081439
[TBL] [Abstract][Full Text] [Related]
15. The Use of Alcohol, Tobacco, Illegal Drugs and Medicines: An Estimate of Consumption and Substance-Related Disorders in Germany.
Atzendorf J; Rauschert C; Seitz NN; Lochbühler K; Kraus L
Dtsch Arztebl Int; 2019 Sep; 116(35-36):577-584. PubMed ID: 31587705
[TBL] [Abstract][Full Text] [Related]
16. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
[TBL] [Abstract][Full Text] [Related]
17. Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people.
Cheeta S; Halil A; Kenny M; Sheehan E; Zamyadi R; Williams AL; Webb L
BMJ Open; 2018 Nov; 8(11):e021109. PubMed ID: 30401725
[TBL] [Abstract][Full Text] [Related]
18. Harms associated with psychoactive substances: findings of the UK National Drug Survey.
Morgan CJ; Muetzelfeldt L; Muetzelfeldt M; Nutt DJ; Curran HV
J Psychopharmacol; 2010 Feb; 24(2):147-53. PubMed ID: 19939875
[TBL] [Abstract][Full Text] [Related]
19. Single chemical entity legal highs: assessing the risk for long term harm.
McNabb CB; Russell BR; Caprioli D; Nutt DJ; Gibbons S; Dalley JW
Curr Drug Abuse Rev; 2012 Dec; 5(4):304-19. PubMed ID: 23244343
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of substance use and substance use disorders in Germany].
Küfner H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Apr; 53(4):271-83. PubMed ID: 20232026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
